Global Site
Latin America
Brazil
South Africa
United Arab Emirates
Austria
French Canadian
United Kingdom
United States
Italia
Nederlands
Deutschland
Canada
France
Czech RepublicLet’s Heal™ is the result of 75 years experience in developing our products to help you test, protect, promote and comfort the wound towards healing.
PROMOGRAN PRISMA®
PROMOGRAN PRISMA® matrix is a freeze-dried composite of collagen, oxidised regenerated cellulose (ORC) and silver. Made from a matrix of 55% collagen, 44% ORC and 1% ORC/Silver.
PROMOGRAN PRISMA® is designed to ‘kick start’ the healing process while providing protection from infection.1-2
In the presence of exudate PROMOGRAN PRISMA® matrix transforms into a soft and conformable, biodegradable gel; this allows contact with all areas of the wound. With PROMOGRAN PRISMA® stalled wounds heal:
- Faster3-5
- Cost Effectively3,6
- While providing protection from infection7-8
Latest News
- Early Adoption of Collagen/ORC Therapies Improves Clinical Outcome
- The combination of Collagen/ORC/silver provides superior reduction of proteases
- Significantly higher percentage of wounds healed and reduced risk of infection with PROMOGRAN PRISMA®
Disclaimer:
The product information on this page is not intended to be used by health care professionals or users in the United States and may not comply with the regulatory standards of the United States – please click the link above for product information in respect of products used in the United States.
© Systagenix Wound Management 2011. Brands marked with ® or ™ are trademarks of Systagenix. All other products referenced herein are acknowledged to be trademarks of their respective owners.
PROMOGRAN PRISMA® references
1. Cullen B et al. ORC/Collagen Matrix Containing Silver Controls Bacterial Bioburden while Retaining Dermal Cell viability. Poster presented at EWMA Prague, May 2006
2. Gregory S et al. The Ability of ORC/Collagen containing silver to reduce Bioburden and retain dermail Cell Viability. Johnson & Johnson Wound Management, Gargrave, UK. Poster presented at ETRS Stuttgart, September 2005
3. Nisi G et al. Use of protease-modulating matrix in the treatment of pressure sores. Chir Ital 2005;57:465-8
4. Lazaro-Martinez et al. Randomized comparative trial of a collagen/oxidized regenerated cellulose dressing in the treatment of neuropathic diabetic foot ulcers. F.R. Circ. Esp.2007, 82(1), 27-31
5. Veves A et al. A randomized , controlled trial of PROMOGRAN® (a collagen/oxidised regenerated cellulose dressing) vs standard treatments in the management of diabetic foot ulcers. Arch Surg 2002;137:822-827
6. Cullen, B., Domnelly, T., Rennison, T. Can excessive levels of silver be detrimental to healing? SAWC, San Diego, 2008
7. Gregory S et al. The Ability of ORC/Collagen containing silver to reduce Bioburden and retain dermail Cell Viability. Johnson & Johnson Wound Management, Gargrave, UK. Poster presented at ETRS Stuttgart, September 2005
8. Cullen, B., Nisbet, L., Gibson, M., Lanzara, S., Zamboni, P. A clinical study examining the effect of ORC/Collagen/Silver-ORC on healing and wound biochemistry. SAWC, Dallas, 2009
11. (relates to graph) Cullen, B., Kemp, L., Essler, L. Rebalancing wound biochemistry improves healing: a clinical study examining effect of PROMOGRAN. Wound Repair Regen. 2004 12(2) A4.